These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11785380)

  • 1. [Use of molecular biological method (MAPREC-test) for evaluating residual neurovirulence and genetic stability of oral poliovirus vaccine type 3].
    Rumiantsev AA; Grachev VP; Kozlov VG; Karganova GG
    Vopr Virusol; 2001; 46(6):11-5. PubMed ID: 11785380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the neurovirulence of poliovirus by non-radioisotope molecular analysis to quantify genomic changes.
    Horie H; Tano Y; Doi Y; Hashizume S
    Biologicals; 1998 Dec; 26(4):289-97. PubMed ID: 10403032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods to Monitor Molecular Consistency of Oral Polio Vaccine.
    Chumakov KM
    Methods Mol Biol; 2016; 1387():263-77. PubMed ID: 26983740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
    Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
    Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence.
    Chumakov KM; Norwood LP; Parker ML; Dragunsky EM; Ran YX; Levenbook IS
    J Virol; 1992 Feb; 66(2):966-70. PubMed ID: 1309923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
    Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
    Levenbook I; Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine.
    Rezapkin GV; Chumakov KM; Lu Z; Ran Y; Dragunsky EM; Levenbook IS
    Virology; 1994 Jul; 202(1):370-8. PubMed ID: 8009849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying low-frequency revertants in oral poliovirus vaccine using next generation sequencing.
    Sarcey E; Serres A; Tindy F; Chareyre A; Ng S; Nicolas M; Vetter E; Bonnevay T; Abachin E; Mallet L
    J Virol Methods; 2017 Aug; 246():75-80. PubMed ID: 28456668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased safety level of serotype 3 Sabin oral poliomyelitis vaccine lots by improved seed virus, and tissue culture and virus infection conditions.
    Dörsam V; Weimer T; Schmeel A; Hein B; Enssle K; Chumakov KM; Fibi MR
    Vaccine; 2000 May; 18(22):2435-43. PubMed ID: 10738101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan.
    Yoshida H; Horie H; Matsuura K; Miyamura T
    Lancet; 2000 Oct; 356(9240):1461-3. PubMed ID: 11081527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine.
    Chumakov KM; Powers LB; Noonan KE; Roninson IB; Levenbook IS
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):199-203. PubMed ID: 1846038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New assays for the quality control of live oral poliovirus vaccine.
    Furesz J; Levenbook I
    Acta Microbiol Immunol Hung; 1998; 45(3-4):391-9. PubMed ID: 9873944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the new control methods for oral poliomyelitis vaccine.
    Grachev VP; Karganova GG; Rumyantsev AA; Ivanova OE; Eremeeva TP; Drozdov SG
    Dev Biol (Basel); 2001; 105():211-7. PubMed ID: 11763330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay.
    Gnanashanmugam D; Falkovitz-Halpern MS; Dodge A; Fang M; Wong LJ; Esparza M; Hammon R; Rivas-Merelles EE; Santos JI; Maldonado Y
    J Clin Microbiol; 2007 Aug; 45(8):2419-25. PubMed ID: 17581940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the viral RNA sequence heterogeneity for control of OPV neurovirulence.
    Chumakov K; Norwood L; Parker M; Dragunsky E; Taffs R; Ran Y; Ridge J; Levenbook I
    Dev Biol Stand; 1993; 78():79-89; discussion 88-9. PubMed ID: 8388834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory tests for live attenuated poliovirus vaccines.
    Wood DJ; Macadam AJ
    Biologicals; 1997 Mar; 25(1):3-15. PubMed ID: 9167004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccines.
    Neverov A; Chumakov K
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20063-8. PubMed ID: 21041640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the accumulation of mutants in Sabin attenuated polio vaccine viruses passaged in Vero cells.
    Horie H; Miyazawa M; Ota Y; Wakabayashi K; Yoshida H; Doi Y; Hashizume S
    Vaccine; 2001 Jan; 19(11-12):1456-9. PubMed ID: 11163668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutants in polio vaccine viruses using pooled antipoliovirus monoclonal antibodies.
    Horie H; Sato-Miyazawa M; Ota Y; Wakabayashi K; Doi T; Yoshizawa K; Doi Y; Hashizume S
    Biologicals; 1999 Sep; 27(3):217-26. PubMed ID: 10652177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.